Details for 2015817642
Up to date per 01.04.2026
Actions
Details for 2015817642
Deleted
European Patent
11.10.2017 A
25.11.2020 B1
05.12.2014
EP
14196591
A61K 9/14 20060101AFI20200527BHEP
Owner
Aragon Pharmaceuticals, Inc.10990 Wilshire Blvd, Suite 300 Los Angeles, CA 90024US
Representative
Representative
Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT
Inventor
VERRECK, Geertc/o Janssen Pharmaceutica NV Turnhoutseweg 30 2340 BeerseBE